Skip to main content

Table 3 Predictors of cardiovascular and all-cause mortality in type 2 diabetes mellitus patients

From: Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study

Predictor

HR* (95% CI)

HR** (95% CI)

HR*** (95% CI)

HR**** (95% CI)

Cardiovascular mortality

 D-Dmax > 4.26 mg/l

5.43 (1.99–14.79)

5.79 (2.08–16.16)

5.08 (1.85–13.9)

6.85 (1.85–13.90)

 D-Drate < 0.07 mg/l/min

2.97 (1.07–8.23)

4.52 (1.47–13.86)

3.49 (1.24–9.82)

3.77 (1.33–10.69)

 Peak thrombin > 283.5 nM

5.65 (2.07–15.51)

9.23 (2.97–28.86)

6.50 (2.34–18.18)

7.10 (2.52–20.05)

All-cause mortality

 D-Dmax > 4.26 mg/l

3.48 (1.45–8.39)

3.61 (1.49–8.77)

3.45 (1.43–8.30)

3.85 (1.57–9.44)

 D-Drate < 0.07 mg/l/min

3.29 (1.31–8.28)

3.97 (1.50–10.46)

3.28 (1.03–8.24)

3.06 (1.18–7.90)

 Peak thrombin > 283.5 nM

6.54 (2.78–15.35)

9.66 (3.72–25.09)

6.69 (2.85–15.69)

7.91 (3.28–19.07)

  1. D-Dmax, D-Drate and peak thrombin were dichotomized using the cut-off value found in the receiver operating curves that optimally classified the cardiovascular and all-cause death. Data were presented as hazard ratio (HR) with 95% confidence interval (CI) calculated in multivariable Cox proportional hazards survival regression
  2. D-Dmax maximum concentration of D-dimer concentration released from the clot during lysis induced by tissue plasminogen activator, D-Drate maximum rates of increase in D-dimer levels
  3. Hazard ratios adjusted for sex and age (*); for sex, age and cardiovascular disease history (**); for sex, age and nephropathy (***); for sex, age and metformin (****)